Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abelmoschus Manihot vs Losartan in IgA Nephropathy
NCT02231125Phase 4Unknown
- Start
- Sep 2014
- Primary completion
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of huang kui capsule in IgA nephropathy (IgAN) (2 arms). Primary endpoint: Change in 24-h proteinuria at 48 weeks. Status: unknown.
02
Drugs
huang kui capsule
03
Conditions
IgA nephropathy (IgAN)
Beyond the preview
Go deeper on NCT02231125.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02231125.